Research output: Contribution to journal › Article › peer-review
| Translated title of the contribution | Efficacy and safety of inclisiran, evolocumab and alirocumab in patients with high, very high and extreme cardiovascular risk |
|---|---|
| Original language | Russian |
| Article number | 13 |
| Pages (from-to) | 112-118 |
| Number of pages | 7 |
| Journal | Russian Journal of Cardiology |
| Volume | 30 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2025 |
ID: 67647191